Jazz Pharmaceuticals (JAZZ)
246.81
-0.76 (0.31%)
Upcoming Events
Latest Headlines
Canaccord Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
September 1, 2026 6:58 AM - StreetInsider
Form 144 Jazz Pharmaceuticals Filed by: Iannone Robert
August 27, 2026 4:31 PM - SEC Filing
Jazz Pharmaceuticals prices $1.1B exchangeable notes offering due 2032
August 27, 2026 12:30 AM - StreetInsider
Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
August 27, 2026 12:30 AM - PR NewsWire
Jazz Pharmaceuticals (JAZZ) PT Raised to $277 at RBC Capital
August 26, 2026 9:00 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $322 at Morgan Stanley
August 26, 2026 8:16 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $310 at Needham
August 26, 2026 7:12 AM - StreetInsider
Jazz Pharmaceuticals plans $1B note offering and share buyback
August 26, 2026 7:00 AM - StreetInsider
Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
August 26, 2026 7:00 AM - PR NewsWire
Jazz Pharmaceuticals (JAZZ) PT Raised to $281 at Truist Securities
August 26, 2026 6:58 AM - StreetInsider
Canaccord Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
August 26, 2026 6:35 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $300 at Deutsche Bank
August 26, 2026 3:09 AM - StreetInsider
Form 8-K Jazz Pharmaceuticals For: Aug 25
August 25, 2026 4:07 PM - SEC Filing
FDA approves Jazz Pharmaceuticals' Ziihera for HER2+ stomach cancer
August 25, 2026 10:00 AM - StreetInsider
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
August 25, 2026 10:00 AM - PR NewsWire
Biotech funding rises 75% this year as M&A activity continues
August 17, 2026 5:16 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $283 at Morgan Stanley
August 11, 2026 9:09 AM - StreetInsider
Form 8-K Jazz Pharmaceuticals For: Aug 10
August 10, 2026 5:13 PM - SEC Filing
Form 8-K Jazz Pharmaceuticals For: Aug 10
August 10, 2026 7:41 AM - SEC Filing
Jazz Pharmaceuticals to acquire Actio Biosciences for $820M upfront
August 10, 2026 7:30 AM - StreetInsider
Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio
August 10, 2026 7:30 AM - PR NewsWire
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Pearce Samantha
August 7, 2026 6:01 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Winningham Rick E
August 7, 2026 5:57 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: LOVE TED W
August 7, 2026 5:55 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Hamill Laura
August 7, 2026 5:51 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Kennedy Patrick
August 7, 2026 5:48 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Smith Mark Douglas
August 7, 2026 5:46 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Cook Jennifer E.
August 7, 2026 5:44 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Mulligan Seamus
August 7, 2026 5:42 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: McSharry Heather Ann
August 7, 2026 5:39 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: ENRIGHT PATRICK G
August 7, 2026 5:37 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: RIEDEL NORBERT G
August 7, 2026 5:34 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: COZADD BRUCE C
August 7, 2026 5:32 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: ORiordan Anne
August 7, 2026 2:09 PM - SEC Filing
Form SCHEDULE 13G Jazz Pharmaceuticals Filed by: FMR LLC
August 6, 2026 10:31 AM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 03 Filed by: COZADD BRUCE C
August 5, 2026 4:33 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $275 at Stifel
August 4, 2026 8:49 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $276 at JPMorgan
August 4, 2026 8:13 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $280 at Morgan Stanley
August 4, 2026 8:12 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised at TD Cowen Following 'Nice Topline Beat And Raise'
August 4, 2026 8:12 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $300 at Wells Fargo
August 4, 2026 8:06 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $292 at Needham
August 4, 2026 7:33 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $264 at Truist Securities
August 4, 2026 7:09 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $273 at RBC Capital
August 4, 2026 7:05 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised at Piper Sandler as 'Zepzelca Strength Continues'
August 4, 2026 6:55 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $280 at Baird
August 4, 2026 6:13 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $270 at Barclays
August 4, 2026 3:58 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) Misses Q2 EPS by 47c; raises guidance
August 3, 2026 4:24 PM - StreetInsider
Form 144 Jazz Pharmaceuticals Filed by: COZADD BRUCE C
August 3, 2026 4:17 PM - SEC Filing
Form 10-Q Jazz Pharmaceuticals For: Jun 30
August 3, 2026 4:09 PM - SEC Filing
Form 8-K Jazz Pharmaceuticals For: Aug 03
August 3, 2026 4:07 PM - SEC Filing
Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results
August 3, 2026 4:05 PM - PR NewsWire
Form 8-K Jazz Pharmaceuticals For: Jul 23
August 3, 2026 8:48 AM - SEC Filing
Form 8-K Jazz Pharmaceuticals For: Jul 23
July 24, 2026 6:16 AM - SEC Filing
Raymond James sees potential for beats across biopharma coverage
July 21, 2026 6:12 AM - StreetInsider
Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026
July 20, 2026 4:15 PM - PR NewsWire
Canaccord Starts Jazz Pharmaceuticals (JAZZ) at Buy
July 16, 2026 4:07 PM - StreetInsider
Form DEFA14A Jazz Pharmaceuticals
July 14, 2026 4:36 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $285 at Wells Fargo
July 14, 2026 6:25 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $260 at Barclays
July 14, 2026 5:12 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Lowered to $254 at Truist Securities
July 7, 2026 7:09 AM - StreetInsider
Form 4 Jazz Pharmaceuticals For: Jul 01 Filed by: COZADD BRUCE C
July 6, 2026 6:23 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 30 Filed by: Pearce Samantha
July 2, 2026 6:28 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 30 Filed by: GALA RENEE D
July 2, 2026 6:22 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 30 Filed by: Iannone Robert
July 2, 2026 6:17 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 30 Filed by: Patil Neena M
July 2, 2026 6:10 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 30 Filed by: Johnson Philip L
July 2, 2026 6:05 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: COZADD BRUCE C
July 1, 2026 3:55 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 15 Filed by: Smith Mark Douglas
June 17, 2026 4:45 PM - SEC Filing
Jazz Pharmaceuticals and AbCellera ink antibody research deal
June 17, 2026 7:01 AM - StreetInsider
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
June 17, 2026 7:00 AM - BizWire
Jazz Pharmaceuticals presents Xywav sleep disorder data at SLEEP 2026 conference
June 16, 2026 4:06 PM - StreetInsider
Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Nar
June 16, 2026 4:05 PM - PR NewsWire
Form 144 Jazz Pharmaceuticals Filed by: Smith Mark Douglas
June 15, 2026 4:09 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Jun 10 Filed by: Patil Neena M
June 12, 2026 4:15 PM - SEC Filing
Jazz's Zepzelca fails late-stage lung cancer trial
June 12, 2026 8:01 AM - StreetInsider
Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer
June 12, 2026 8:00 AM - PR NewsWire
Form 144 Jazz Pharmaceuticals Filed by: Patil Neena M
June 10, 2026 4:05 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $307 at BofA Securities
June 10, 2026 5:22 AM - StreetInsider
Bernstein SocGen Reiterates Market Perform Rating on Jazz Pharmaceuticals (JAZZ)
June 9, 2026 9:27 AM - StreetInsider
Truist Securities Assumes Jazz Pharmaceuticals (JAZZ) at Buy
June 9, 2026 6:06 AM - StreetInsider
Form ARS Jazz Pharmaceuticals For: Dec 31
June 8, 2026 4:10 PM - SEC Filing
Form DEFA14A Jazz Pharmaceuticals
June 8, 2026 4:07 PM - SEC Filing
Form DEF 14A Jazz Pharmaceuticals For: Jul 23
June 8, 2026 4:06 PM - SEC Filing
Full Article List
